Walter Alexander

News

Well tolerated with promising responses in ALL/LL: Venetoclax plus navitoclax plus chemotherapy

Author:: Walter Alexander

Publish date: December 16, 2020

Delayed count recovery remains a key safety concern.

News

Phase 1 study shows feasibility, safety, efficacy of STAR T cells for ALL

Author:: Walter Alexander

Publish date: December 14, 2020

STAR (synthetic T-cell receptor and antigen receptor) T-cells were reported superior to CAR T cells for acute lym...

News

Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies

Author:: Walter Alexander

Publish date: December 11, 2020

Once-daily oral DTRM-555 shows encouraging activity in Richter’s transformation and DLBCL.

News

Highly effective in Ph-negative B-cell ALL: Hyper-CVAD with sequential blinatumomab

Author:: Walter Alexander

Publish date: December 11, 2020

Favorable MRD negativity and overall survival rates with low higher-grade toxicities suggest that reductions in c...

News

Rechallenge ‘reasonable’ for some with small-cell lung cancer

Author:: Walter Alexander

Publish date: December 10, 2020

Carboplatin plus etoposide significantly prolonged progression-free survival, compared with topotecan, in patients with advanced or relapsed, sensi...

News

Geography and behaviors linked to early-onset colorectal cancer survival in U.S. women

Author:: Walter Alexander

Publish date: December 9, 2020

Physical inactivity and lower fertility correlate modestly with early-onset colorectal cancer mortality in women.

News

Phase 1 study: Beta-blocker may improve melanoma treatment response

Author:: Walter Alexander

Publish date: December 8, 2020

“It’s exciting that an extremely inexpensive drug like propranolol that could be used in every country around the world could have an impact on can...